EMJ Hematology 9 [Supplement 2] . 2021

In this issue

This review article shares insights from a virtual symposium that took place at the European School of Haematology (ESH) 7th Translational Research e-Conference: Myelodysplastic Syndromes. The three leading speakers have provided a summary of presentations on myelodysplastic syndrome (MDS) treatment, with a focus on precision medicine, the immune and inflammatory microenvironments, and therapies for high-risk cases.

Rate this content's potential impact on patient outcomes

Average rating / 5. Vote count:

No votes so far! Be the first to rate this content.